Illumina Inc (ILMN) Q1 2020 Earnings Call Transcript

Illumina Inc (ILMN) Q1 2020 Earnings Call Transcript

Participating for Illumina today will be Francis deSouza, President and Chief Executive Officer; and Sam Samad, Chief Financial Officer.. Francis, will share an update on our business and Sam will review our financial results.. It is our intent that all forward-looking statements regarding our financial results and commercial activity made during today's call will be protected under the Private Securities Litigation Reform Act of 1995.. Some customers are working on ultra high throughput NGS based screening tests for return to work.. China was the first to be impacted by COVID-19 and was the most impacted in the quarter.. Both sequencing systems and sequencing consumables were lower than expected in China in the first quarter and total China revenue was $84 million.. It's not back to business as normal, but we are seeing both research and clinical customers returning to their labs in China and scaling up their operations.. Systems tend to be back-end loaded in any given quarter and system purchases were not considered high priority for many customers at the end of the first quarter.. Finally APJ delivered revenue of $77 million with solid sequencing consumable growth including record shipments in Japan, despite COVID-19 related headwinds.. Runs are reported